Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
New spectroscopy technology reveals insights into the unknown mechanisms underlying amyloid diseases, new research suggests.
Amyloid diseases, such as Alzheimer’s disease, type 2 diabetes and cataracts all share the common trait that proteins aggregate into long fibres which then form plaques.
Unfortunately, laboratory studies have not been unable to locate the source of toxicity as neither the amylin monomer precursors nor the plaques themselves are very toxic.
In new research published via Biomedical Spectroscopy & Imaging (BSI), a group of scientists claim to have found an explanation as to why proteins aggregate into toxic plaques.
http://www.laboratorytalk.com/resea...y-may-explain-protein-toxicity/406763.article
Amyloid diseases, such as Alzheimer’s disease, type 2 diabetes and cataracts all share the common trait that proteins aggregate into long fibres which then form plaques.
Unfortunately, laboratory studies have not been unable to locate the source of toxicity as neither the amylin monomer precursors nor the plaques themselves are very toxic.
In new research published via Biomedical Spectroscopy & Imaging (BSI), a group of scientists claim to have found an explanation as to why proteins aggregate into toxic plaques.
http://www.laboratorytalk.com/resea...y-may-explain-protein-toxicity/406763.article